Poetsch Micaela, Konrad Helen, Helmus Janine, Bajanowski Thomas, von Wurmb-Schwark Nicole
Institute of Legal Medicine, University Hospital Essen, Hufelandstr. 55, D-45122, Essen, Germany.
ForScix GmbH, Hamburg, Germany.
Int J Legal Med. 2016 Jul;130(4):935-940. doi: 10.1007/s00414-016-1352-1. Epub 2016 Mar 14.
DNA quantification is an important step in the molecular genetic analysis of a forensic sample, hopefully providing reliable data on DNA content for a subsequent generation of reproducible STR profiles for identification. For several years, this quantification has usually been done by real-time PCR protocols and meanwhile a variety of assays are commercially available from different companies. The newest one is the PowerQuant(TM) assay by Promega Inc. which is advertised with the promise that a determined DNA concentration of 0 ng/μl in a forensic sample guarantees the impossibility to achieve true STR results, thus allowing to exclude such samples from STR analysis to save time and money. Thus, the goal of this study was to thoroughly verify the quantification step with regard to its suitability as a screening method. We have evaluated the precision and reliability of four different real-time PCR quantification assays by systematically testing DNA dilutions and forensic samples with various DNA contents. Subsequently, each sample was subjected to the Powerplex® ESX 17 fast kit to determine a reliable cutoff level for exclusion of definitely negative samples from STR analysis. An accurate quantification of different cell line DNA dilutions was not possible with any kit. However, at least the PowerQuant(TM) assay provided suitable data analyzing forensic samples, whereas in other systems up to 46 % of negative samples still displayed reliable STR analysis results. All in all, the PowerQuant(TM) assay represents a big step forward, but the evaluation of real-time PCR quantification results has still to be done with great care.
DNA定量是法医样本分子遗传分析中的重要一步,有望为后续用于鉴定的可重复STR图谱提供关于DNA含量的可靠数据。多年来,这种定量通常通过实时PCR方案进行,同时不同公司有多种商业检测方法可供使用。最新的一种是Promega公司的PowerQuant™检测法,该检测法宣称,法医样本中确定的DNA浓度为0 ng/μl可确保无法获得真实的STR结果,从而可以将此类样本排除在STR分析之外,以节省时间和金钱。因此,本研究的目的是全面验证定量步骤作为一种筛选方法的适用性。我们通过系统地检测不同DNA含量的DNA稀释液和法医样本,评估了四种不同实时PCR定量检测法的精密度和可靠性。随后,对每个样本使用Powerplex® ESX 17快速试剂盒,以确定一个可靠的截断水平,用于将绝对阴性样本排除在STR分析之外。使用任何试剂盒都无法对不同细胞系DNA稀释液进行准确的定量。然而,至少PowerQuant™检测法在分析法医样本时提供了合适的数据,而在其他系统中,高达46%的阴性样本仍显示出可靠的STR分析结果。总的来说,PowerQuant™检测法代表了一大进步,但对实时PCR定量结果的评估仍需格外谨慎。